Two more biotechs, Marea and North Immunology, do reverse mergers
The reverse merger party is still buzzing. This time, it's a cardio and endocrine startup with two drugs in Phase 2 and a biotech working on a long-acting immunology and inflammation (I&I) drug. Mid-stage Marea ...
September 17, 2026 11:35 AM EDT StartupsDeals Reverse merger run extends as Marea, North Immunology line up deals with $405M in backing Kyle LaHucik Biotech Correspondent The reverse merger party is still buzzing. This time, it’s a cardio and endocrine startup with two drugs in Phase 2 and a biotech working … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that